Roberta Murphy & Jonny Martell- Psilocybin assisted... clinical trials for depression and anorexia

Psilocybin-assisted psychotherapy in clinical trials for depression and anorexia involves significant relational and contextual complexities. Research indicates that the psychedelic experience is heavily influenced by non-pharmacological factors such as set, setting, and the strength of the therapeutic alliance. Success in these trials often depends on the team's ability to facilitate deep emotional work, which requires a blend of both explicit narrative building and implicit, experiential support. The scientific pursuit of medical legitimacy often leads to institutional constraints that may limit the depth and scope of psychotherapeutic processes. While standardized protocols are common in clinical research, they may not always accommodate the unpredictable, deeply personal journeys inherent in psychedelic experiences. Ensuring ethical care and integration is crucial for maximizing positive outcomes while minimizing potential harm, particularly when dealing with long-standing trauma.